Russell Investments Group
LNAI

Russell Investments Group’s Lunai Bioworks LNAI Stock Holding History

Russell Investments Group’s Portfolio LNAI Stock Details LNAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-40
Closed -$2.67K – 3867
2024
Q4 		$2.67K Buy
+40
New +$2.65K ﹤0.01% 3392
2021
Q1 		– Sell
-90
Closed -$21K – 3181
2020
Q4 		$21K Sell
90
-443
-83% -$112K ﹤0.01% 2979
2020
Q3 		$152K Buy
+533
New +$168K ﹤0.01% 2879

Other funds holding LNAI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Russell Investments Group's LNAI Position: Q1 2025 in Review

Russell Investments Group sold out of Lunai Bioworks (LNAI) in Q1 2025, closing a stake of 40 shares — an estimated $2.67K sold.

Russell Investments Group first reported a position in LNAI in Q3 2020 and held it in 3 quarters. The position peaked at $152K in Q3 2020. 60 funds tracked by Wall St. Rank hold LNAI as of Q1 2025.

  • Russell Investments Group reported no remaining Lunai Bioworks position as of Q1 2025 after selling out during the quarter.
  • Russell Investments Group sold 40 Lunai Bioworks shares in Q1 2025, an estimated $2.67K.
  • Russell Investments Group first reported a position in Lunai Bioworks in Q3 2020 and held it in 3 quarters.
  • Russell Investments Group's Lunai Bioworks position peaked at $152K in Q3 2020.
  • 60 funds tracked by Wall St. Rank held Lunai Bioworks as of Q1 2025.

Based on Russell Investments Group's 13F filing for Q1 2025, filed 13 May 2025.